Invitrogen™ Gateway™ pT-Rex™-DEST30 Vector

Description

Includes

All destination vectors are provided lyophilized and supercoiled.

Requires

Gateway entry clone, Gateway LR Clonase™ enzyme mix, and reaction buffer.

Destination vectors for expression in E. coli, insect, yeast, or mammalian cells, as well as for production of native protein or N- or C-terminal fusion proteins

• Destination vectors have attR sites for recombination with any attL-flanked fragment, regardless of whether it is entry clone or UltimateRF Clone

Cloning, Gateway Cloning, Mammalian Expression, Protein Expression, Proteins, Expression, Isolation and Analysis/Regulated Expression

Specifications

• Constitutive or Inducible System: Inducible
• Delivery Type: Transfection
• Inducing Agent: Tetracycline
• Promoter: CMV/TO
• Product Type: Gateway System Destination Expression Vector
• Selection Agent (Eukaryotic): Neomycin⁄Kanamycin
• Content And Storage: All destination vectors are provided lyophilized and supercoiled.
• Protein Tag: Untagged
• Cloning Method: Gateway
• Quantity: 6 μg
• Vector: pDEST
• Product Line: Gateway™, T-REx™
• For Use With (Application): Regulated Expression

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov

For Research Use Only. Not for use in diagnostic procedures.